Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Monosodium Molybdate(vi)
2. Na2moo4
3. Sodium Molybdate(vi)
4. Sodium Molybdate(vi), 99mo-labeled Cpd
5. Sodium Molybdate(vi), Dihydrate
6. Sodium Molybdenum Oxide
1. 7631-95-0
2. Disodium Molybdate
3. Sodium Molybdate(vi)
4. Molybdate Disodium
5. Sodium Molybdenum Oxide
6. Natriummolybdat
7. Molybdic Acid, Disodium Salt
8. Sodium Molybdate (anhydrous)
9. Disodium;dioxido(dioxo)molybdenum
10. Anhydric Sodium Molybdate
11. Sodium Molybdate, Anhydrous
12. 13466-16-5
13. 948qaq08i1
14. Mfcd00003486
15. Sodium Molybdenum Oxide, Anhydrous, Mo 46.2%
16. Natriummolybdat [german]
17. Sodium Molybdate (van)
18. Sodium Dimolybdate
19. Ccris 5442
20. Na2moo4
21. Einecs 231-551-7
22. Nsc 77389
23. Sodium Molybdate Anhydrous
24. Molybdic Acid (h2moo4), Disodium Salt
25. Molybdic Acid (h2moo4) , Disodium Salt
26. Unii-948qaq08i1
27. Molybdate (moo42-), Disodium, (t-4)-
28. Molybdenum (as Sodium)
29. Disodium Tetraoxomolybdate
30. Sodium Molybdate (anh.)
31. Molybdate (moo42-), Disodium, (beta-4)-
32. Molybdic Acid, Sodium Salt
33. Ec 231-551-7
34. Sodium Molybdate, >=98%
35. Ddisodium Molybdate Dihydrate
36. Sodium Molybdate, Acs Grade
37. Sodium Dioxido(dioxo)molybdenum
38. Sodium Molybdate 35% Solution
39. Sodium Molybdate Solution 35%
40. Sodium Molybdate [inci]
41. Sodium Molybdate [vandf]
42. Chebi:75215
43. Sodium Molybdate [mart.]
44. Sodium Molybdate [who-dd]
45. Sodium Molybdate(vi) [mi]
46. Sodium Molybdate, Lr, >=99.5%
47. Nsc-77389
48. Akos015912969
49. Db14496
50. Molybdenum (as Sodium) [vandf]
51. Sodium Molybdate Crystals, Technical Grade
52. Ft-0701280
53. Sodium Molybdate Dihydrate (technical Grade)
54. Molybdate (moo42-), Sodium (1:2), (t-4)-
55. Q414518
56. Sodium Molybdate, Anhydrous, Powder, -100 Mesh Particle Size, 99.9% Trace Metals Basis
| Molecular Weight | 205.93 g/mol |
|---|---|
| Molecular Formula | MoNa2O4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | 207.864601 g/mol |
| Monoisotopic Mass | 207.864601 g/mol |
| Topological Polar Surface Area | 80.3 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 62.2 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
77
PharmaCompass offers a list of Sodium Molybdate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Molybdate manufacturer or Sodium Molybdate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Molybdate manufacturer or Sodium Molybdate supplier.
PharmaCompass also assists you with knowing the Sodium Molybdate API Price utilized in the formulation of products. Sodium Molybdate API Price is not always fixed or binding as the Sodium Molybdate Price is obtained through a variety of data sources. The Sodium Molybdate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 13466-16-5 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 13466-16-5, including repackagers and relabelers. The FDA regulates 13466-16-5 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 13466-16-5 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 13466-16-5 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 13466-16-5 supplier is an individual or a company that provides 13466-16-5 active pharmaceutical ingredient (API) or 13466-16-5 finished formulations upon request. The 13466-16-5 suppliers may include 13466-16-5 API manufacturers, exporters, distributors and traders.
click here to find a list of 13466-16-5 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 13466-16-5 DMF (Drug Master File) is a document detailing the whole manufacturing process of 13466-16-5 active pharmaceutical ingredient (API) in detail. Different forms of 13466-16-5 DMFs exist exist since differing nations have different regulations, such as 13466-16-5 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 13466-16-5 DMF submitted to regulatory agencies in the US is known as a USDMF. 13466-16-5 USDMF includes data on 13466-16-5's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 13466-16-5 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 13466-16-5 suppliers with USDMF on PharmaCompass.
A 13466-16-5 CEP of the European Pharmacopoeia monograph is often referred to as a 13466-16-5 Certificate of Suitability (COS). The purpose of a 13466-16-5 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 13466-16-5 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 13466-16-5 to their clients by showing that a 13466-16-5 CEP has been issued for it. The manufacturer submits a 13466-16-5 CEP (COS) as part of the market authorization procedure, and it takes on the role of a 13466-16-5 CEP holder for the record. Additionally, the data presented in the 13466-16-5 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 13466-16-5 DMF.
A 13466-16-5 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 13466-16-5 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 13466-16-5 suppliers with CEP (COS) on PharmaCompass.
13466-16-5 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 13466-16-5 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 13466-16-5 GMP manufacturer or 13466-16-5 GMP API supplier for your needs.
A 13466-16-5 CoA (Certificate of Analysis) is a formal document that attests to 13466-16-5's compliance with 13466-16-5 specifications and serves as a tool for batch-level quality control.
13466-16-5 CoA mostly includes findings from lab analyses of a specific batch. For each 13466-16-5 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
13466-16-5 may be tested according to a variety of international standards, such as European Pharmacopoeia (13466-16-5 EP), 13466-16-5 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (13466-16-5 USP).